Similar biotherapeutic products in Latin America. Regulation and opportunities for patients with autoimmune diseases
Biotherapeutic products have revolutionized medicine, changing the way we can treat some chronic diseases, such as autoimmune diseases. The patent expiry and the high costs of reference biotherapeutic products, among other factors, have promoted interest in similar biotherapeutic products (SBPs), al...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2013
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/26401
- Acceso en línea:
- https://doi.org/10.2147/bs.s38572
https://repository.urosario.edu.co/handle/10336/26401
- Palabra clave:
- Biological therapy
Biotechnology
Similar biotherapeutic product
Autoimmune disease
Latin America
- Rights
- License
- Abierto (Texto Completo)